Related Experiment Video
Updated: Mar 27, 2026

06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
16.9K
Cell Proliferation in Neuroblastoma.
Laura L Stafman1, Elizabeth A Beierle2
1Department of Surgery, Division of Pediatric Surgery, University of Alabama, Birmingham, AL 35233, USA. lstafman@uabmc.edu.
Cancers
|January 16, 2016
Summary
Neuroblastoma cell proliferation is driven by transcription factors, kinases, and cell cycle regulators. Targeting these factors offers new therapeutic strategies for advanced or relapsed neuroblastoma.
Area of Science:
- Pediatric oncology
- Cancer biology
- Molecular targets
Background:
- Neuroblastoma is the most common childhood extracranial solid tumor.
- Advanced or relapsed neuroblastoma has a poor prognosis.
Purpose of the Study:
- To review factors driving neuroblastoma cell proliferation.
- To discuss novel therapeutic strategies targeting these factors.
Main Methods:
- Literature review of factors influencing neuroblastoma cell growth.
- Analysis of transcription factors, kinases, and cell cycle regulators.
- Discussion of emerging therapeutic targets.
Main Results:
- Identified key transcription factors, kinases, and cell cycle regulators promoting neuroblastoma growth.
- Highlighted the potential of targeting these specific pathways.
- Summarized novel therapeutic approaches for neuroblastoma.
Conclusions:
- Understanding neuroblastoma cell proliferation is crucial for treatment.
- Targeting specific molecular pathways offers promising therapeutic avenues.
- Novel strategies may improve outcomes for high-risk neuroblastoma patients.

